Delivery Order SPE2DB20D7059-SPE2DB24FPTK1
Award Date
10/20/23
Potential Completion Date
10/23/23
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,371.32 and covers the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,271.70, is for the delivery of Fluticasone Propionate HFA 44 MCG 10.6GM, a medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,882.24, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 20, 2024. The contract was not designated with a set-aside requirement....
This federal contract award, with the ID SPE2DB22D3301|SPE2DB24FY8ES, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, and has a ceiling value of $6,360.78. It is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is June 10, 2024. The contract is not...
This federal contract award, with an ID of SPE2DB20D1051|SPE2DB24FD8EU, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a ceiling value of $1,267.94 and a completion date of May 31, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This contract award is not associated with any set-aside designation....
This federal contract award, valued at $3,173.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 9, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside....
This federal contract award, valued at $3,428.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024 and uses a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open...
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FY9R1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a ceiling value of $5,876.94. The contract type is Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of January 30, 2025. The contract is not...
This federal contract award, with the ID SPE2DB22D3501|SPE2DB25FTN17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,680.33, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 19, 2024. This contract is...
This federal contract award, with the ID SPE2DB22D2005|SPE2DB24FJMK5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,351.88, is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of May 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen...